IRulya Therapeutics QNCX
NASDAQ QNCX
$32.83 -1.85 (-5.33%)
At close: Oct 22, 2026 · 4:00 PM EDT

Quince Therapeutics (QNCX) Asset Writedowns and Impairment (2022 - 2026)

Updated

IRulya Therapeutics' Asset Writedowns and Impairment came in at $67.81 million for Q1 2026.

Analysis

Quince Therapeutics (QNCX) Asset Writedowns and Impairment (2022 - 2026) Analysis & Trends

For FY2024, IRulya Therapeutics' Asset Writedowns and Impairment was $17.13 million, up 190.3% from FY2023.

  • Going back by year, Asset Writedowns and Impairment was $5.9 million in FY2023 and $136,000 in FY2022.
  • The Q1 2026 figure represents the lowest quarterly Asset Writedowns and Impairment since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 IRulya Therapeutics 201.34 Mn 229.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 67.81 Mn
Jun 30, 2024 17.13 Mn
Sep 30, 2023 5.83 Mn
Mar 31, 2023 66,000.00
Sep 30, 2022 38,000.00
API Access

Quince Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=QNCX&period=max&api_key=YOUR_API_KEY